All News

travel3.jpg

Travel During COVID-19 Pandemic

d Jack Cush, MD

The CDC has addressed the effects and the issues of domestic and international travel on its website.  Below is a sampling of key advice.

Read Article

Copay Assistance Programs Help Patients but Confuse Them Too

d MedPage Today

"If you're having trouble paying for your medications, Drug Company X may be able to help."

Read Article
podcast logo

RheumNow Podcast – Steroids, IVIG & the Vaccine (1.15.2021)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...

Read Article
44 pts of Inclusion body myositis were randomized to either PBO or sirolimus 2 mg/d. At 12 mos there were no signif differences betw groups for motor strength , but sirolimus had more SAEs (45 vs 27%); yet sirolimus had better HAQ, FVC & 6-min walk times. https://t.co/YhnRTnaGFl

Links:

Dr. John Cush RheumNow ( View Tweet)

The NEJM has featured an overview of Osteoarthritis of the Knee. https://t.co/1AaNICygOr

Links:

Dr. John Cush RheumNow ( View Tweet)

Belated congratulations to Dr. David T. Felson, for receiving the Lee C. Howley, Sr. Prize for Arthritis Science from the Arthritis Foundation. He is a professor of medicine and epidemiology at Boston University's Schools of Medicine and Public Health https://t.co/U7yKnWWLxc

Links:

Dr. John Cush RheumNow ( View Tweet)

ACR Convergence 2020 Fireside Chats- top presentations in nr-axSpA, AS, axial PsA and Still’s disease. Sponsored by Novartis Medical Affairs Unable to attend the key sessions at #ACR20? Listen to the experts as they weigh in on the top abstracts. https://t.co/cUj5T3reyG

Links:

Dr. John Cush RheumNow ( View Tweet)

New QD Clinic—This week’s videos: Clinic Emergencies, Stopping Meds, 3 Issues After COVID Vaccination, My New Clinic COVID Routine, Raynaud's or Not https://t.co/R0zcRq6Sg1

Links:

Dr. John Cush RheumNow ( View Tweet)

Copay Assistance Programs Help Patients but Confuse Them Too https://t.co/WuPkwrE3ZF

Links:

Dr. John Cush RheumNow ( View Tweet)

Type I interferon (IFN1) produced by plasmacytoid dendritic cells are prime drivers of adaptive immunity. Study of 137 SLE pts shows that baseline IFN1 scores correl w/ Dz activity, # flares, prednisone doses, immunosuppressive use over 5 yrs https://t.co/OGb4NfrcIU

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more... https://t.co/f0wWTm2kV5

Links:

Dr. John Cush RheumNow ( View Tweet)

New Download Available on COVID-19 & mRNA Vaccines https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinic - What to do After COVID Vaccination https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY

Links:

Dr. John Cush RheumNow ( View Tweet)
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond. https://t.co/QisCpdcLEa https://t.co/pZekUvcomE

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatologists: Record your question or case for the RheumNow podcast. https://t.co/wzNmOzH4VE https://t.co/dgTTvRqESI

Links:

Dr. John Cush RheumNow ( View Tweet)
ProDERM Study: IVIG in Dermatomyositis--The ProDERM study show that IVIg is safe, effective and superior to placebo in patients with dermatomyositis (DM). https://t.co/HOB8CYn9yc https://t.co/AmT3AQdawa

Links:

Dr. John Cush RheumNow ( View Tweet)
Real good historic review of RA drug development wherein Dr Paul Emery interviews Dr. Mike Weinblatt - Good Listen from the Cytokine Signaling Forum podcast https://t.co/R7rg7AwVlG

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Stopping Meds https://t.co/zhtAHLeGqT https://t.co/rFmCch4WJ4

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR Convergence 2020 Fireside Chats – top presentations in Still’s disease Sponsored by Novartis Medical Affairs Unable to attend all the key sessions at ACR Convergence 2020? Listen to the experts as they present their views on the top abstracts. https://t.co/MD6lU5oIvy

Links:

Dr. John Cush RheumNow ( View Tweet)

Long Term Safety and Efficacy of Tacrolimus in Lupus Nephritis--Takeuchi et al has published their extensive experience with long-term tacrolimus use in lupus nephritis patients showing its real-world safety and efficacy. https://t.co/hgMp5GcyFA https://t.co/Xdxg3v3wMm

Links:

Dr. John Cush RheumNow ( View Tweet)
×